, Columnist
Consider This a Warning on Cancer-Drug Combos
The hype over these treatments has dramatically outpaced delivery.
Lots of promise, but watch out for the pitfalls.
Photographer: AstraSeneca
This article is for subscribers only.
The pharmaceutical industry believes that the lucrative future of cancer treatment lies in combining immune-boosting medicines with other drugs to boost their effectiveness. But that future is still a ways off, and the present is pretty ugly.
It’s something to keep in mind as one of the year’s biggest cancer conferences gets underway in Chicago.